Targeting the human gut microbiome with small-molecule inhibitors

Highly accurate protein structure prediction with AlphaFold

Jumper, J., Evans, R., Pritzel, A., Green, T., Figurnov, M., Ronneberger, O., Tunyasuvunakool, K., Bates, R., Žídek, A., Potapenko, A., et al. (2021) · Nature · doi:10.1038/s41586-021-03819-2 · Cited by 43,764

Structure, function and diversity of the healthy human microbiome

The Human Microbiome Project Consortium (2012) · Nature · doi:10.1038/nature11234 · Cited by 11,726

Dietary Modulation of the Human Colonic Microbiota: Introducing the Concept of Prebiotics

Gibson, G. R., & Roberfroid, M. B. (1995) · Journal of Nutrition · doi:10.1093/jn/125.6.1401 · Cited by 7,659

Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease

Wang, Z., Klipfell, E., Bennett, B. J., Koeth, R., Levison, B. S., DuGar, B., Feldstein, A. E., Britt, E. B., Fu, X., Chung, Y.-M., et al. (2011) · Nature · doi:10.1038/nature09922 · Cited by 5,597

Probiotics in man and animals

AFRC, R. F. (1989) · Journal of Applied Bacteriology · doi:10.1111/j.1365-2672.1989.tb05105.x · Cited by 4,831

Interaction between microbiota and immunity in health and disease

Zheng, D., Liwinski, T., & Elinav, E. (2020) · Cell Research · doi:10.1038/s41422-020-0332-7 · Cited by 3,947

Current understanding of the human microbiome

Gilbert, J. A., Blaser, M. J., Caporaso, J. G., Jansson, J. K., Lynch, S. V., & Knight, R. (2018) · Nature Medicine · doi:10.1038/nm.4517 · Cited by 2,609

Population-level analysis of gut microbiome variation

Falony, G., Joossens, M., Vieira-Silva, S., Wang, J., Darzi, Y., Faust, K., Kurilshikov, A., Bonder, M. J., Valles-Colomer, M., Vandeputte, D., et al. (2016) · Science · doi:10.1126/science.aad3503 · Cited by 2,400

Topoisomerase I inhibitors: camptothecins and beyond

Pommier, Y. G. (2006) · Nature reviews. Cancer · doi:10.1038/nrc1977 · Cited by 2,362

Molecular Analysis of Commensal Host-Microbial Relationships in the Intestine

Hooper, L. V., Wong, M. H., Thelin, A., Hansson, L., Falk, P. G., & Gordon, J. I. (2001) · Science · doi:10.1126/science.291.5505.881 · Cited by 2,202

Disentangling type 2 diabetes and metformin treatment signatures in the human gut microbiota

MetaHIT consortium, Forslund, K., Hildebrand, F., Nielsen, T., Falony, G., Le Chatelier, E., Sunagawa, S., Prifti, E., Vieira-Silva, S., Gudmundsdottir, V., et al. (2015) · Nature · doi:10.1038/nature15766 · Cited by 2,116

Metformin alters the gut microbiome of individuals with treatment-naive type 2 diabetes, contributing to the therapeutic effects of the drug

Wu, H., Esteve, E., Tremaroli, V., Khan, M. T., Caesar, R., Mannerås-Holm, L., Ståhlman, M., Olsson, L. M., Serino, M., Planas-Fèlix, M., et al. (2017) · Nature Medicine · doi:10.1038/nm.4345 · Cited by 1,632

Oceanic Methane Biogeochemistry

Reeburgh, W. S. (2007) · Chemical Reviews · doi:10.1021/cr050362v · Cited by 1,588

An increase in the Akkermansia spp. population induced by metformin treatment improves glucose homeostasis in diet-induced obese mice

Shin, N.-R., Lee, J.-C., Lee, H.-Y., Kim, M.-S., Whon, T. W., Lee, M.-S., & Bae, J.-W. (2014) · Gut · doi:10.1136/gutjnl-2012-303839 · Cited by 1,550

MEASUREMENT OF IN SITU ACTIVITIES OF NONPHOTOSYNTHETIC MICROORGANISMS IN AQUATIC AND TERRESTRIAL HABITATS

Staley, J. T., & Konopka, A. E. (1985) · Annual Review of Microbiology · doi:10.1146/annurev.mi.39.100185.001541 · Cited by 1,512

Gut microbiota in colorectal cancer: mechanisms of action and clinical applications

Wong, S. H., & Yu, J. (2019) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-019-0209-8 · Cited by 1,392

Non-lethal Inhibition of Gut Microbial Trimethylamine Production for the Treatment of Atherosclerosis

Wang, Z., Roberts, A. B., Buffa, J. A., Levison, B. S., Zhu, W., Org, E., Gu, X., Huang, Y., Zamanian-Daryoush, M., Culley, M. K., et al. (2015) · Cell · doi:10.1016/j.cell.2015.11.055 · Cited by 1,317

Probiotics in man and animals.

Fuller, R. (1989) · PubMed · Cited by 1,292

Parkinson’s disease: etiopathogenesis and treatment

Jankovic, J. J., & Tan, E. K. (2020) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2019-322338 · Cited by 1,273

Defining the human microbiome

Ursell, L. K., Metcalf, J. L., Parfrey, L. W., & Knight, R. (2012) · Nutrition Reviews · doi:10.1111/j.1753-4887.2012.00493.x · Cited by 1,255

Sulfate-Reducing Bacteria: Principal Methylators of Mercury in Anoxic Estuarine Sediment

Compeau, G. C., & Bartha, R. (1985) · Applied and Environmental Microbiology · doi:10.1128/aem.50.2.498-502.1985 · Cited by 1,226

Quantitative microbiome profiling links gut community variation to microbial load

Vandeputte, D., Kathagen, G., D’hoe, K., Vieira-Silva, S., Valles-Colomer, M., Sabino, J., Wang, J., Tito, R. Y., De Commer, L., Darzi, Y., et al. (2017) · Nature · doi:10.1038/nature24460 · Cited by 1,218

Growing Unculturable Bacteria

Stewart, E. J. (2012) · Journal of Bacteriology · doi:10.1128/jb.00345-12 · Cited by 1,212

Probiotics, gut microbiota, and their influence on host health and disease

Sánchez, B., Delgado, S., Blanco‐Míguez, A., Lourenço, A., Gueimonde, M., & Margolles, A. (2017) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201600240 · Cited by 1,104

Alleviating Cancer Drug Toxicity by Inhibiting a Bacterial Enzyme

Wallace, B. D., Wang, H., Lane, K. T., Scott, J. E., Orans, J., Koo, J. S., Venkatesh, M., Jobin, C., Yeh, L.-A., Mani, S., et al. (2010) · Science · doi:10.1126/science.1191175 · Cited by 1,080

Interaction between drugs and the gut microbiome

Weersma, R. K., Zhernakova, A., & Fu, J. (2020) · Gut · doi:10.1136/gutjnl-2019-320204 · Cited by 1,028

Host-Derived Nitrate Boosts Growth of E. coli in the Inflamed Gut

Winter, S. E., Winter, M. G., Xavier, M. N., Thiennimitr, P., Poon, V., Keestra, A. M., Laughlin, R. C., Gomez, G., Wu, J., Lawhon, S. D., et al. (2013) · Science · doi:10.1126/science.1232467 · Cited by 1,019

Microbial modulation of innate defense: goblet cells and the intestinal mucus layer

Deplancke, B., & Gaskins, H. R. (2001) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/73.6.1131s · Cited by 1,012

Antibiotics as Major Disruptors of Gut Microbiota

Ramirez, J., Guarner, F., Fernández, L. B., Saito, A. M., Sdepanian, V. L., & Cohen, H. (2020) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2020.572912 · Cited by 981

The gut microbiome: Relationships with disease and opportunities for therapy

Durack, J., & Lynch, S. V. (2018) · The Journal of Experimental Medicine · doi:10.1084/jem.20180448 · Cited by 979

Untitled work

(1958) · PubMed · Cited by 978

The effects of antibiotics on the microbiome throughout development and alternative approaches for therapeutic modulation

Langdon, A. E., Crook, N., & Dantas, G. A. (2016) · Genome Medicine · doi:10.1186/s13073-016-0294-z · Cited by 968

Metabolic dependencies drive species co-occurrence in diverse microbial communities

Zelezniak, A., Andrejev, S., Ponomarova, O., Mende, D. R., Bork, P., & Patil, K. R. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1421834112 · Cited by 930

Molybdenum cofactors, enzymes and pathways

Schwarz, G., Mendel, R. R., & Ribbe, M. W. (2009) · Nature · doi:10.1038/nature08302 · Cited by 872

Bacteriophage targeting of gut bacterium attenuates alcoholic liver disease

Duan, Y., Llorente, C., Lang, S., Brandl, K., Chu, H., Jiang, L., White, R. C., Clarke, T. H., Nguyen, K., Torralba, M., et al. (2019) · Nature · doi:10.1038/s41586-019-1742-x · Cited by 850

Autotrophic Nitrification in Bacteria

Prosser, J. I. (1990) · Advances in microbial physiology/Advances in Microbial Physiology · doi:10.1016/s0065-2911(08)60112-5 · Cited by 843

The promise and peril of chemical probes

Arrowsmith, C. H., Audia, J. E., Austin, C., Baell, J., Bennett, J., Blagg, J., Bountra, C., Brennan, P. E., Brown, P. J., Bunnage, M. E., et al. (2015) · Nature Chemical Biology · doi:10.1038/nchembio.1867 · Cited by 839

Host–microbiota interactions in inflammatory bowel disease

Caruso, R., Lo, B. C., & Núñez, G. (2020) · Nature reviews. Immunology · doi:10.1038/s41577-019-0268-7 · Cited by 808

Review: microbial transformations of human bile acids

Guzior, D. V., & Quinn, R. A. (2021) · Microbiome · doi:10.1186/s40168-021-01101-1 · Cited by 795

Interplay between the human gut microbiome and host metabolism

Visconti, A., Le Roy, C. I., Rosa, F., Rossi, N., Martin, T. C., Mohney, R. P., Li, W., de Rinaldis, E., Bell, J. T., Venter, J. C., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-12476-z · Cited by 782

Discovery and inhibition of an interspecies gut bacterial pathway for Levodopa metabolism

Maini Rekdal, V., Bess, E. N., Bisanz, J. E., Turnbaugh, P. J., & Balskus, E. P. (2019) · Science · doi:10.1126/science.aau6323 · Cited by 753

Clinical pharmacokinetics and metabolism of irinotecan (CPT-11).

Mathijssen, R. H. J., van Alphen, R. J., Verweij, J., Loos, W. J., Nooter, K., Stoter, G., & Sparreboom, A. (2001) · PubMed · Cited by 744

Discovery and characterization of gut microbiota decarboxylases that can produce the neurotransmitter tryptamine

Williams, B. B., Van Benschoten, A. H., Cimermancic, P., Donia, M. S., Zimmermann, M., Taketani, M., Ishihara, A., Kashyap, P. C., Fraser, J. S., & Fischbach, M. A. (2014) · Cell Host & Microbe · doi:10.1016/j.chom.2014.09.001 · Cited by 732

Identifying Genetic Determinants Needed to Establish a Human Gut Symbiont in Its Habitat

Goodman, A. L., McNulty, N. P., Zhao, Y., Leip, D., Mitra, R. D., Lozupone, C., Knight, R. D., & Gordon, J. I. (2009) · Cell Host & Microbe · doi:10.1016/j.chom.2009.08.003 · Cited by 713

Microbial conversion of choline to trimethylamine requires a glycyl radical enzyme

Craciun, S., & Balskus, E. P. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1215689109 · Cited by 701

Clinical Practice Guideline by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA): 2021 Focused Update Guidelines on Management of Clostridioides difficile Infection in Adults

Johnson, S., Lavergne, V., Skinner, A. M., Gonzales-Luna, A. J., Garey, K. W., Kelly, C. P., & Wilcox, M. H. (2021) · Clinical Infectious Diseases · doi:10.1093/cid/ciab549 · Cited by 696

Understanding the glucoregulatory mechanisms of metformin in type 2 diabetes mellitus

Foretz, M., Guigas, B., & Viollet, B. (2019) · Nature Reviews Endocrinology · doi:10.1038/s41574-019-0242-2 · Cited by 686

Regulatory effects of bifidobacteria on the growth of other colonic bacteria

Gibson, G. R., & Wang, X. (1994) · Journal of Applied Bacteriology · doi:10.1111/j.1365-2672.1994.tb03443.x · Cited by 682

Phylogeny of Dissimilatory Sulfite Reductases Supports an Early Origin of Sulfate Respiration

Wagner, M., Roger, A. J., Flax, J. L., Brusseau, G. A., & Stahl, D. A. (1998) · Journal of Bacteriology · doi:10.1128/jb.180.11.2975-2982.1998 · Cited by 680

Modulation of gut microbiota by berberine and metformin during the treatment of high-fat diet-induced obesity in rats

Zhang, X., Zhao, Y., Xu, J., Xue, Z., Zhang, M., Pang, X., Zhang, X., & Zhao, L. (2015) · Scientific Reports · doi:10.1038/srep14405 · Cited by 630

Review: Fifty years of research on rumen methanogenesis: lessons learned and future challenges for mitigation

Beauchemin, K. A., Ungerfeld, E. M., Eckard, R. J., & Wang, M. (2020) · Animal · doi:10.1017/s1751731119003100 · Cited by 619

Mouse Microbiota Models: Comparing Germ-Free Mice and Antibiotics Treatment as Tools for Modifying Gut Bacteria

Kennedy, E. A., King, K. Y., & Baldridge, M. T. (2018) · Frontiers in Physiology · doi:10.3389/fphys.2018.01534 · Cited by 602

New CRISPR–Cas systems from uncultivated microbes

Burstein, D. E., Harrington, L. B., Strutt, S. C., Probst, A. J., Anantharaman, K., Thomas, B. C., Doudna, J. A., & Banfield, J. F. (2016) · Nature · doi:10.1038/nature21059 · Cited by 583

Longitudinal multi-omics of host–microbe dynamics in prediabetes

Zhou, W., Sailani, M. R., Contrepois, K., Zhou, Y., Ahadi, S., Leopold, S. R., Zhang, M. J., Rao, V., Avina, M., Mishra, T., et al. (2019) · Nature · doi:10.1038/s41586-019-1236-x · Cited by 583

Understanding the mechanisms of faecal microbiota transplantation

Khoruts, A., & Sadowsky, M. J. (2016) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2016.98 · Cited by 579

Fecal microbiota transplantation: Review and update

Wang, J.-W., Kuo, C.-H., Kuo, F.-C., Wang, Y.-K., Hsu, W.-H., Yu, F.-J., Hu, H.-M., Hsu, P.-I., Wang, J.-Y., & Wu, D.-C. (2019) · Journal of the Formosan Medical Association · doi:10.1016/j.jfma.2018.08.011 · Cited by 576

Dynamic modulation of the gut microbiota and metabolome by bacteriophages in a mouse model

Hsu, B. B., Gibson, T. E., Yeliseyev, V., Liu, Q., Lyon, L., Bry, L., Silver, P. A., & Gerber, G. K. (2019) · Cell Host & Microbe · doi:10.1016/j.chom.2019.05.001 · Cited by 573

Development of a gut microbe–targeted nonlethal therapeutic to inhibit thrombosis potential

Roberts, A. B., Gu, X., Buffa, J. A., Hurd, A. G., Wang, Z., Zhu, W., Gupta, N., Skye, S. M., Cody, D. B., Levison, B. S., et al. (2018) · Nature Medicine · doi:10.1038/s41591-018-0128-1 · Cited by 552

Precision editing of the gut microbiota ameliorates colitis

Zhu, W., Winter, M. G., Byndloss, M. X., Spiga, L., Duerkop, B. A., Hughes, E. R., Büttner, L., Romão, E. D. L., Behrendt, C. L., Lopez, C. A., et al. (2018) · Nature · doi:10.1038/nature25172 · Cited by 550

Bile Acid-Activated Receptors, Intestinal Microbiota, and the Treatment of Metabolic Disorders

Fiorucci, S., & Distrutti, E. (2015) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2015.09.001 · Cited by 539

Gut bacterial tyrosine decarboxylases restrict levels of levodopa in the treatment of Parkinson’s disease

van Kessel, S. P., Frye, A. K., El-Gendy, A. O., Castejon, M., Keshavarzian, A., van Dijk, G., & El Aidy, S. (2019) · Nature Communications · doi:10.1038/s41467-019-08294-y · Cited by 521

Exploring host–microbiota interactions in animal models and humansPreprint

Kostic, A. D., Howitt, M. R., & Garrett, W. S. (2013) · Genes & Development · doi:10.1101/gad.212522.112 · Cited by 516

Statin therapy is associated with lower prevalence of gut microbiota dysbiosis

Vieira‐Silva, S., Falony, G., Belda, E., Nielsen, T., Aron‐Wisnewsky, J., Chakaroun, R., Forslund, S. K., Assmann, K. E., Valles‐Colomer, M., Nguyen, T. T. D., et al. (2020) · Nature · doi:10.1038/s41586-020-2269-x · Cited by 509

Taxonomic profiling and populational patterns of bacterial bile salt hydrolase (BSH) genes based on worldwide human gut microbiome

Song, Z., Cai, Y., Lao, X., Wang, X., Lin, X., Cui, Y., Kalavagunta, P. K., Liao, J., Jin, L., Shang, J., et al. (2019) · Microbiome · doi:10.1186/s40168-019-0628-3 · Cited by 505

Use of “Specific” Inhibitors in Biogeochemistry and Microbial Ecology

Oremland, R. S., & Capone, D. G. (1988) · Advances in Microbial Ecology · doi:10.1007/978-1-4684-5409-3_8 · Cited by 498

Personalized Mapping of Drug Metabolism by the Human Gut Microbiome

Javdan, B., Lopez, J. G., Chankhamjon, P., Lee, Y.-C. J., Hull, R., Wu, Q., Wang, X., Chatterjee, S., & Donia, M. S. (2020) · Cell · doi:10.1016/j.cell.2020.05.001 · Cited by 492

Gut microbiota: a potential new territory for drug targeting

Jia, W. P., Li, H., Zhao, L., & Nicholson, J. K. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2505 · Cited by 478

Longitudinal Multi-omics Reveals Subset-Specific Mechanisms Underlying Irritable Bowel Syndrome

Mars, R. A. T., Yang, Y., Ward, T., Houtti, M., Priya, S., Lekatz, H. R., Tang, X., Sun, Z., Kalari, K. R., Korem, T., et al. (2020) · Cell · doi:10.1016/j.cell.2020.08.007 · Cited by 456

Enhanced antiinflammatory capacity of a Lactobacillus plantarum mutant synthesizing modified teichoic acids

Grangette, C., Nutten, S., Palumbo, E., Morath, S., Hermann, C., Dewulf, J., Pot, B., Härtung, T., Pascal Hols, A., & Mercenier, A. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0504084102 · Cited by 443

The gnotobiotic animal as a tool in the study of host microbial relationships

Gordon, H. A., & Pesti, L. (1971) · Bacteriological Reviews · doi:10.1128/br.35.4.390-429.1971 · Cited by 432

Selective inhibitors of biosynthesis of aminergic neurotransmitters

Kollonitsch, J., Patchett, A. A., Marburg, S., Maycock, A. L., Perkins, L. M., Doldouras, G. A., Duggan, D. E., & Aster, S. D. (1978) · Nature · doi:10.1038/274906a0 · Cited by 423

Bile Acid Sulfation: A Pathway of Bile Acid Elimination and Detoxification

Alnouti, Y. (2009) · Toxicological Sciences · doi:10.1093/toxsci/kfn268 · Cited by 404

Volatile Fatty Acids and Hydrogen as Substrates for Sulfate-Reducing Bacteria in Anaerobic Marine Sediment

S�rensen, J. N., Christensen, D., & Jørgensen, B. B. (1981) · Applied and Environmental Microbiology · doi:10.1128/aem.42.1.5-11.1981 · Cited by 402

Analyses of gut microbiota and plasma bile acids enable stratification of patients for antidiabetic treatment

Gu, Y., Wang, X., Li, J., Zhang, Y., Zhong, H., Liu, R., Zhang, D., Feng, Q., Xie, X., Hong, J., et al. (2017) · Nature Communications · doi:10.1038/s41467-017-01682-2 · Cited by 402

Gut microbial β-glucuronidases reactivate estrogens as components of the estrobolome that reactivate estrogens

Ervin, S. M., Li, H., Lim, L., Roberts, L. R., Liang, X., Mani, S., & Redinbo, M. R. (2019) · Journal of Biological Chemistry · doi:10.1074/jbc.ra119.010950 · Cited by 397

Nitrogen Fixation in the Marine Environment

Capone, D. G., & Carpenter, E. J. (1982) · Science · doi:10.1126/science.217.4565.1140 · Cited by 379

Origins and Early Evolution of the Mevalonate Pathway of Isoprenoid Biosynthesis in the Three Domains of Life

Lombard, J., & Moreira, D. (2010) · Molecular Biology and Evolution · doi:10.1093/molbev/msq177 · Cited by 375

Associations of gut-flora-dependent metabolite trimethylamine-N-oxide, betaine and choline with non-alcoholic fatty liver disease in adults

Chen, Y., Liu, Y., Zhou, R.-F., Chen, X., Wang, C., Tan, X., Wang, L., Zheng, R.-D., Zhang, H., Ling, W., et al. (2016) · Scientific Reports · doi:10.1038/srep19076 · Cited by 370

An exclusive metabolic niche enables strain engraftment in the gut microbiota

Shepherd, E. S., DeLoache, W. C., Pruss, K. M., Whitaker, W. R., & Sonnenburg, J. L. (2018) · Nature · doi:10.1038/s41586-018-0092-4 · Cited by 367

Gnotobiotic mouse model of phage–bacterial host dynamics in the human gut

Reyes, A., Wu, M., McNulty, N. P., Rohwer, F. L., & Gordon, J. I. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1319470110 · Cited by 355

Microbial Respiration and Formate Oxidation as Metabolic Signatures of Inflammation-Associated Dysbiosis

Hughes, E. R., Winter, M. G., Duerkop, B. A., Spiga, L., Furtado de Carvalho, T., Zhu, W., Gillis, C. C., Büttner, L., Smoot, M. P., Behrendt, C. L., et al. (2017) · Cell Host & Microbe · doi:10.1016/j.chom.2017.01.005 · Cited by 353

Understanding the impact of antibiotic perturbation on the human microbiome

Schwartz, D. J., Langdon, A. E., & Dantas, G. A. (2020) · Genome Medicine · doi:10.1186/s13073-020-00782-x · Cited by 348

Reduction of Ferric Iron in Anaerobic, Marine Sediment and Interaction with Reduction of Nitrate and Sulfate

Sørensen, J. (1982) · Applied and Environmental Microbiology · doi:10.1128/aem.43.2.319-324.1982 · Cited by 340

CONTROL OF NITRIFICATION BY 2-CHLORO-6-(TRICHLORO-METHYL) PYRIDINE

GORING, C. A. I. (1962) · Soil Science · doi:10.1097/00010694-196203000-00010 · Cited by 323

Cholesterol Metabolism by Uncultured Human Gut Bacteria Influences Host Cholesterol Level

Kenny, D. J., Plichta, D. R., Shungin, D., Koppel, N., Hall, A. B., Fu, B., Vasan, R. S., Shaw, S. Y., Vlamakis, H. C., Balskus, E. P., et al. (2020) · Cell Host & Microbe · doi:10.1016/j.chom.2020.05.013 · Cited by 319

Gut reactions: Breaking down xenobiotic–microbiome interactions

Clarke, G., Sandhu, K. V., Griffin, B. T., Dinan, T. G., Cryan, J. F., & Hyland, N. P. (2019) · Pharmacological Reviews · doi:10.1124/pr.118.015768 · Cited by 319

Preparation of coenzyme M analogs and their activity in the methyl coenzyme M reductase system of Methanobacterium thermoautotrophicum

Gunsalus, R. P., Romesser, J. A., & WOLFE, R. S. (1978) · Biochemistry · doi:10.1021/bi00605a019 · Cited by 310

Rapid gut dysbiosis induced by stroke exacerbates brain infarction in turn

Xu, K., Gao, X., Xia, G., Chen, M., Zeng, N., Wang, S., You, C., Tian, X., Di, H., Tang, W., et al. (2021) · Gut · doi:10.1136/gutjnl-2020-323263 · Cited by 308

Emerging roles of bile acids in mucosal immunity and inflammation

Chen, M. L., Takeda, K., & Sundrud, M. S. (2019) · Mucosal Immunology · doi:10.1038/s41385-019-0162-4 · Cited by 305

Microbiota-Targeted Therapies: An Ecological Perspective

Lemon, K. P., Armitage, G. C., Relman, D. A., & Fischbach, M. A. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3004183 · Cited by 285

General methods for the analysis of metabolic profiles of bile acids and related compounds in feces.

Setchell, K. D. R., Lawson, A. M., Tanida, N., & Sjövall, J. (1983) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)37923-2 · Cited by 285

Structure and Inhibition of Microbiome β-Glucuronidases Essential to the Alleviation of Cancer Drug Toxicity

Wallace, B. D., Roberts, A. B., Pollet, R. M., Ingle, J. D., Biernat, K. A., Pellock, S. J., Venkatesh, M. K., Guthrie, L., O’Neal, S. K., Robinson, S. J., et al. (2015) · Chemistry & Biology · doi:10.1016/j.chembiol.2015.08.005 · Cited by 285

Impaired renal function and dysbiosis of gut microbiota contribute to increased trimethylamine-N-oxide in chronic kidney disease patients

Xu, K., Xia, G., Lu, J.-Q., Chen, M.-X., Zhen, X., Wang, S., You, C., Nie, J., Zhou, H., & Yin, J. (2017) · Scientific Reports · doi:10.1038/s41598-017-01387-y · Cited by 268

Glycosidase inhibition: assessing mimicry of the transition state

Gloster, T. M., & Davies, G. J. (2009) · Organic & Biomolecular Chemistry · doi:10.1039/b915870g · Cited by 253

Impact of short-chain galactooligosaccharides on the gut microbiome of lactose-intolerant individuals

Azcárate-Peril, M. A., Ritter, A. J., Savaiano, D. A., Monteagudo-Mera, A., Anderson, C., Magness, S. T., & Klaenhammer, T. R. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1606722113 · Cited by 252

Metagenomic engineering of the mammalian gut microbiome in situ

Ronda, C., Chen, S. P., Cabral, V., Yaung, S. J., & Wang, H. H. (2019) · Nature Methods · doi:10.1038/s41592-018-0301-y · Cited by 246

Antibiotic-induced changes in the human gut microbiota for the most commonly prescribed antibiotics in primary care in the UK: a systematic review

Elvers, K. T., Wilson, V. J., Hammond, A., Duncan, L., Huntley, A. L., Hay, A. D., & van der Werf, E. T. (2020) · BMJ Open · doi:10.1136/bmjopen-2019-035677 · Cited by 246

Phylogeny, culturing, and metagenomics of the human gut microbiota

Walker, A. W., Duncan, S. H., Louis, P., & Flint, H. J. (2014) · Trends in Microbiology · doi:10.1016/j.tim.2014.03.001 · Cited by 239

Therapeutic Modulation of Microbiota-Host Metabolic Interactions

Holmes, E. C., Kinross, J. K., Gibson, G. R., Burcelin, R., Jia, W. P., Pettersson, S., & Nicholson, J. K. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3004244 · Cited by 237

Glucuronides in the gut: Sugar-driven symbioses between microbe and host

Pellock, S. J., & Redinbo, M. R. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.r116.767434 · Cited by 232

Targeted inhibition of gut bacterial β-glucuronidase activity enhances anticancer drug efficacy

Bhatt, A. P., Pellock, S. J., Biernat, K. A., Walton, W. G., Wallace, B. D., Creekmore, B. C., Letertre, M. P. M., Swann, J. R., Wilson, I. D., Roques, J., et al. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1918095117 · Cited by 228

Microbial metabolic exchange—the chemotype-to-phenotype link

Phelan, V. V., Liu, W.-T., Pogliano, K., & Dorrestein, P. C. (2011) · Nature Chemical Biology · doi:10.1038/nchembio.739 · Cited by 220

Interrelations between sulfate-reducing and methane-producing bacteria in bottom deposits of a fresh-water lake. I. Field observations

Cappenberg, T. E. (1974) · Antonie van Leeuwenhoek · doi:10.1007/bf00394387 · Cited by 216

Association between microbiota-dependent metabolite trimethylamine-N-oxide and type 2 diabetes

Shan, Z., Sun, T., Huang, H., Chen, S., Chen, L., Luo, C., Yang, W., Yang, X., Yao, P., Cheng, J., et al. (2017) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.117.157107 · Cited by 210

Anti-inflammatory properties of Lactobacillus gasseri expressing manganese superoxide dismutase using the interleukin 10-deficient mouse model of colitis

Carroll, I. M., Andrus, J. M., Bruno-Bárcena, J. M., Klaenhammer, T. R., Hassan, H. M., & Threadgill, D. S. (2007) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00132.2007 · Cited by 208

Inter-individual differences in the gene content of human gut bacterial species

Zhu, A., Sunagawa, S., Mende, D. R., & Bork, P. (2015) · Genome biology · doi:10.1186/s13059-015-0646-9 · Cited by 205

The exogenous origin of trimethylamine in the mouse

Al-Waiz, M., Mikov, M., Mitchell, S. C., & Smith, R. L. (1992) · Metabolism · doi:10.1016/0026-0495(92)90140-6 · Cited by 196

Fecal microbiota transplant in severe and severe-complicatedClostridium difficile: A promising treatment approach

Fischer, M., Sipe, B. W., Cheng, Y., Phelps, E. L., Rogers, N. A., Sagi, S. V., Bohm, M. E., Xu, H., & Kassam, Z. (2016) · Gut Microbes · doi:10.1080/19490976.2016.1273998 · Cited by 195

Thermal proteome profiling in bacteria: probing protein state in vivo

Mateus, A., Bobonis, J., Kurzawa, N., Stein, F., Helm, D., Hevler, J. F., Typas, A., & Savitski, M. M. (2018) · Molecular Systems Biology · doi:10.15252/msb.20188242 · Cited by 192

Clostridium difficile infection and antibiotic-associated diarrhoea

Mullish, B. H., & Williams, H. R. T. (2018) · Clinical Medicine · doi:10.7861/clinmedicine.18-3-237 · Cited by 191

Fecal recovery in humans of viable Bifidobacterium sp ingested in fermented milk

Bouhnik, Y., Pochart, P., Marteau, P. R., Arlet, G., Goderel, I., & Rambaud, J. C. (1992) · Gastroenterology · doi:10.1016/0016-5085(92)90172-u · Cited by 187

Effects of Acarbose on the Gut Microbiota of Prediabetic Patients: A Randomized, Double-blind, Controlled Crossover Trial

Zhang, X., Fang, Z., Zhang, C., Xia, H., Jie, Z., Han, X., Chen, Y., & Ji, L. (2017) · Diabetes Therapy · doi:10.1007/s13300-017-0226-y · Cited by 187

Targeted Inhibition of Gut Microbial Trimethylamine N-Oxide Production Reduces Renal Tubulointerstitial Fibrosis and Functional Impairment in a Murine Model of Chronic Kidney Disease

Gupta, N., Buffa, J. A., Roberts, A. B., Sangwan, N., Skye, S. M., Li, L., Ho, K. J., Varga, J., DiDonato, J. A., Tang, W. H. W., et al. (2020) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.120.314139 · Cited by 187

A small-molecule inhibitor of BamA impervious to efflux and the outer membrane permeability barrier

Hart, E. M., Mitchell, A. M., Konovalova, A., Grabowicz, M., Sheng, J. R., Han, X., Rodriguez‐Rivera, F. P., Schwaid, A. G., Malinverni, J. C., Balibar, C. J., et al. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1912345116 · Cited by 185

Molybdenum enzymes, their maturation and molybdenum cofactor biosynthesis in Escherichia coli

Iobbi‐Nivol, C., & Leimkühler, S. (2012) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2012.11.007 · Cited by 180

Multiple levels of the unknown in microbiome research

Thomas, A. M., & Segata, N. (2019) · BMC Biology · doi:10.1186/s12915-019-0667-z · Cited by 176

Antibacterial activity of statins: a comparative study of Atorvastatin, Simvastatin, and Rosuvastatin

Masadeh, M. M., Mhaidat, N. M., Alzoubi, K. H., Al-Azzam, S. I., & Alnasser, Z. (2012) · Annals of Clinical Microbiology and Antimicrobials · doi:10.1186/1476-0711-11-13 · Cited by 169

Bacterial β-glucuronidase inhibition protects mice against enteropathy induced by indomethacin, ketoprofen or diclofenac: mode of action and pharmacokinetics

Saitta, K. S., Zhang, C., Lee, K. K., Fujimoto, K., Redinbo, M. R., & Boelsterli, U. A. (2014) · Xenobiotica · doi:10.3109/00498254.2013.811314 · Cited by 165

Alterations in Gut Microbiota by Statin Therapy and Possible Intermediate Effects on Hyperglycemia and Hyperlipidemia

Kim, J., Lee, H., An, J., Song, Y., Lee, C., Kim, K., & Kong, H. (2019) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.01947 · Cited by 164

Statins: a viable candidate for host-directed therapy against infectious diseases

Parihar, S. P., Guler, R., & Brombacher, F. (2018) · Nature reviews. Immunology · doi:10.1038/s41577-018-0094-3 · Cited by 159

Therapeutic significance of β-glucuronidase activity and its inhibitors: A review

Awolade, P., Cele, N., Kerru, N., Gummidi, L., Oluwakemi, E., & Singh, P. (2019) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2019.111921 · Cited by 158

Electron Donors Utilized by Sulfate-Reducing Bacteria in Eutrophic Lake Sediments

Smith, R. L., & Klug, M. J. (1981) · Applied and Environmental Microbiology · doi:10.1128/aem.42.1.116-121.1981 · Cited by 153

Depletion of adenosine triphosphate inDesulfovibrio by oxyanions of group VI elements

Taylor, B. F., & Oremland, R. S. (1979) · Current Microbiology · doi:10.1007/bf02602440 · Cited by 144

Role of Endogenous Microbiota, Probiotics and Their Biological Products in Human Health

Howarth, G. S., & Wang, H. (2013) · Nutrients · doi:10.3390/nu5010058 · Cited by 144

Relationship between Development of Diarrhea and the Concentration of SN‐38, an Active Metabolite of CPT‐11, in the Intestine and the Blood Plasma of Athymic Mice Following Intraperitoneal Administration of CPT‐11

Araki, E., Ishikawa, M., Iigo, M., Koide, T., Itabashi, M., & Hoshi, A. (1993) · Japanese Journal of Cancer Research · doi:10.1111/j.1349-7006.1993.tb02031.x · Cited by 142

Fecal Microbiota Transplantation Eliminates Clostridium difficile in a Murine Model of Relapsing Disease

Seekatz, A. M., Theriot, C. M., Molloy, C. T., Wozniak, K. L., Bergin, I. L., & Young, V. B. (2015) · Infection and Immunity · doi:10.1128/iai.00459-15 · Cited by 141

Molecular Insights into Microbial β-Glucuronidase Inhibition to Abrogate CPT-11 Toxicity

Roberts, A. B., Wallace, B. D., Venkatesh, M. K., Mani, S., & Redinbo, M. R. (2013) · Molecular Pharmacology · doi:10.1124/mol.113.085852 · Cited by 140

Characterization of Choline Trimethylamine-Lyase Expands the Chemistry of Glycyl Radical Enzymes

Craciun, S., Marks, J. A., & Balskus, E. P. (2014) · ACS Chemical Biology · doi:10.1021/cb500113p · Cited by 139

Exploring simvastatin, an antihyperlipidemic drug, as a potential topical antibacterial agent

Thangamani, S., Mohammad, H. T., Abushahba, M. F. N., Hamed, M. I., Sobreira, T. J. P., Hedrick, V., Paul, L. N., & Seleem, M. N. (2015) · Scientific Reports · doi:10.1038/srep16407 · Cited by 138

Effects of the Nitrification Inhibitor 3,4-Dimethylpyrazole Phosphate on Nitrification and Nitrifiers in Two Contrasting Agricultural Soils

Shi, X., Hu, H., Müller, C., He, J., Chen, D., & Suter, H. C. (2016) · Applied and Environmental Microbiology · doi:10.1128/aem.01031-16 · Cited by 137

Acarbose treatment affects the serum levels of inflammatory cytokines and the gut content of bifidobacteria in C hinese patients with type 2 diabetes mellitus

Su, B., Liu, H., Li, J., Sunli, Y., Liu, B., Liu, D., Zhang, P., & Meng, X. (2014) · Journal of Diabetes · doi:10.1111/1753-0407.12232 · Cited by 136

Eradication of Helicobacter pylori Infection Improves Levodopa Action, Clinical Symptoms and Quality of Life in Patients with Parkinson's Disease

Hashim, H., Azmin, S., Razlan, H., Yahya, N. W., Tan, H. J., Manaf, M. R. A., & Ibrahim, N. M. (2014) · PLoS ONE · doi:10.1371/journal.pone.0112330 · Cited by 136

Engineered Probiotic for the Inhibition of Salmonella via Tetrathionate-Induced Production of Microcin H47

Palmer, J. D., Piattelli, E., McCormick, B. A., Silby, M. W., Brigham, C. J., & Bucci, V. (2018) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.7b00114 · Cited by 133

MOLYBDENUM AND NITRATE REDUCTASE

Nicholas, D. J. D., Nason, A., & McElroy, W. D. (1954) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)71274-x · Cited by 128

Effect of cholesterol metabolites and promoting effect of lithocholic acid in colon carcinogenesis in germ-free and conventional F344 rats.

Reddy, B. S., & Watanabe, K. (1979) · PubMed · Cited by 126

Editing of the gut microbiota reduces carcinogenesis in mouse models of colitis-associated colorectal cancer

Zhu, W., Miyata, N., Winter, M. G., Arenales, A., Hughes, E. R., Spiga, L., Kim, J., Sifuentes-Dominguez, L., Starokadomskyy, P., Gopal, P., et al. (2019) · The Journal of Experimental Medicine · doi:10.1084/jem.20181939 · Cited by 126

Towards a mechanistic understanding of reciprocal drug–microbiome interactions

Zimmermann, M., Patil, K. R., Typas, A., & Maier, L. (2021) · Molecular Systems Biology · doi:10.15252/msb.202010116 · Cited by 124

Directed remodeling of the mouse gut microbiome inhibits the development of atherosclerosis

Chen, P. B., Black, A. S., Sobel, A. L., Zhao, Y., Mukherjee, P., Molparia, B., Moore, N. E., Muench, G. R. A., Wu, J., Chen, W., et al. (2020) · Nature Biotechnology · doi:10.1038/s41587-020-0549-5 · Cited by 121

Microbial Manganese Reduction by Enrichment Cultures from Coastal Marine Sediments

Burdige, D. J., & Nealson, K. H. (1985) · Applied and Environmental Microbiology · doi:10.1128/aem.50.2.491-497.1985 · Cited by 120

Contribution of the Gut Microbiome to Drug Disposition, Pharmacokinetic and Pharmacodynamic Variability

Tsunoda, S. M., Gonzales, C., Jarmusch, A. K., Momper, J. D., & JOSEPH, D. R. (2021) · Clinical Pharmacokinetics · doi:10.1007/s40262-021-01032-y · Cited by 120

Effectiveness and safety ofSaccharomyces boulardiifor acute infectious diarrhea

Dinleyici, E. Ç., Eren, M., Özen, M., Yargıç, Z. A., & Vandenplas, Y. (2012) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.2012.664129 · Cited by 118

Establishment and characterization of stable, diverse, fecal-derived in vitro microbial communities that model the intestinal microbiota

Aranda-Díaz, A., Ng, K. M., Thomsen, T., Real-Ramírez, I., Dahan, D., Dittmar, S., Gonzalez, C. G., Chavez, T. M., Vasquez, K. S., Nguyen, T. H., et al. (2022) · Cell Host & Microbe · doi:10.1016/j.chom.2021.12.008 · Cited by 118

Anaerobic Oxidation of Acetylene by Estuarine Sediments and Enrichment Cultures

Culbertson, C. W., Zehnder, A. J. B., & Oremland, R. S. (1981) · Applied and Environmental Microbiology · doi:10.1128/aem.41.2.396-403.1981 · Cited by 117

Effect of classic methanogenic inhibitors on the quantity and diversity of archaeal community and the reductive homoacetogenic activity during the process of anaerobic sludge digestion

Xu, K., Liu, H., & Chen, J. (2009) · Bioresource Technology · doi:10.1016/j.biortech.2009.10.059 · Cited by 117

Development of a covalent inhibitor of gut bacterial bile salt hydrolases

Adhikari, A. A., Seegar, T. C. M., Ficarro, S. B., McCurry, M. D., Ramachandran, D., Yao, L., Chaudhari, S. N., Ndousse-Fetter, S., Banks, A. S., Marto, J. A., et al. (2020) · Nature Chemical Biology · doi:10.1038/s41589-020-0467-3 · Cited by 116

Molybdenum cofactor and human disease

Schwarz, G. (2016) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2016.03.016 · Cited by 115

Microbial enzymes induce colitis by reactivating triclosan in the mouse gastrointestinal tract

Zhang, J., Walker, M. E., Sanidad, K. Z., Zhang, H., Liang, Y., Zhao, E., Chacón-Vargas, K., Yeliseyev, V., Parsonnet, J., Haggerty, T. D., et al. (2022) · Nature Communications · doi:10.1038/s41467-021-27762-y · Cited by 113

High purity galacto-oligosaccharides enhance specific Bifidobacterium species and their metabolic activity in the mouse gut microbiome

Monteagudo-Mera, A., Arthur, J. C., Jobin, C., Keku, T., Bruno-Barcena, J. M., & Azcarate-Peril, M. A. (2016) · Beneficial Microbes · doi:10.3920/bm2015.0114 · Cited by 112

THE MECHANISM OF “ACTIVE SULFATE” FORMATION1

Bandurski, R. S., Wilson, L. G., & Squires, C. L. (1956) · Journal of the American Chemical Society · doi:10.1021/ja01605a028 · Cited by 112

Complete Microbiota Engraftment Is Not Essential for Recovery from Recurrent Clostridium difficile Infection following Fecal Microbiota Transplantation

Staley, C. M., Kelly, C. R., Brandt, L. J., Khoruts, A., & Sadowsky, M. J. (2016) · mBio · doi:10.1128/mbio.01965-16 · Cited by 108

Metagenome analysis of Russian and Georgian Pyophage cocktails and a placebo‐controlled safety trial of single phage versus phage cocktail in healthy Staphylococcus aureus carriers

McCallin, S. E., Sarker, S. A., Sultana, S., Oechslin, F., & Brüssow, H. (2018) · Environmental Microbiology · doi:10.1111/1462-2920.14310 · Cited by 108

β-Glucuronidases of opportunistic bacteria are the major contributors to xenobiotic-induced toxicity in the gut

Dashnyam, P., Mudududdla, R., Hsieh, T.-J., Lin, T.-C., Lin, H.-Y., Chen, P.-Y., Hsu, C.-Y., & Lin, C.-H. (2018) · Scientific Reports · doi:10.1038/s41598-018-34678-z · Cited by 108

Gut microbial β-glucuronidases regulate host luminal proteases and are depleted in irritable bowel syndrome

Edwinson, A. L., Yang, L., Peters, S., Hanning, N., Jeraldo, P., Jagtap, P., Simpson, J. B., Yang, T.-Y., Kumar, P., Mehta, S., et al. (2022) · Nature Microbiology · doi:10.1038/s41564-022-01103-1 · Cited by 105

Determining Microbial Products and Identifying Molecular Targets in the Human Microbiome

Cordy, R. J., Yasuda, K., Shafquat, A., Morgan, X. C., & Huttenhower, C. (2014) · Cell Metabolism · doi:10.1016/j.cmet.2014.10.003 · Cited by 102

Identification and Characterization of a Bile Salt Hydrolase from Lactobacillus salivarius for Development of Novel Alternatives to Antibiotic Growth Promoters

Wang, Z., Zeng, X., Mo, Y., Smith, K., Guo, Y., & Lin, J. (2012) · Applied and Environmental Microbiology · doi:10.1128/aem.02519-12 · Cited by 99

Pharmacological inhibition of bacterial β-glucuronidase prevents irinotecan-induced diarrhea without impairing its antitumor efficacy in vivo

Cheng, K.-W., Tseng, C.-H., Tzeng, C., Leu, Y.-L., Cheng, T.-C., Wang, J., Chang, J., Lu, Y., Cheng, C. C., Chen, I., et al. (2018) · Pharmacological Research · doi:10.1016/j.phrs.2018.10.029 · Cited by 98

Sulfonates: novel electron acceptors in anaerobic respiration

Lie, T. J., Pitta, T. P., Leadbetter, E. R., Godchaux, W., & Leadbetter, J. R. (1996) · Archives of Microbiology · doi:10.1007/s002030050376 · Cited by 96

Chemoproteomic Profiling of Gut Microbiota-Associated Bile Salt Hydrolase Activity

Parasar, B., Zhou, H., Xiao, X., Shi, Q., Brito, I., & Chang, P. V. (2019) · ACS Central Science · doi:10.1021/acscentsci.9b00147 · Cited by 94

DIPHOSPHOPYRIDINE NUCLEOTIDE-NITRATE REDUCTASE FROM ESCHERICHIA COLI

Nicholas, D. J. D., & Nason, A. (1955) · Journal of Bacteriology · doi:10.1128/jb.69.5.580-583.1955 · Cited by 94

Gut Microbial β-Glucuronidase Inhibition via Catalytic Cycle Interception

Pellock, S. J., Creekmore, B. C., Walton, W. G., Mehta, N., Biernat, K. A., Cesmat, A. P., Ariyarathna, Y., Dunn, Z. D., Ли, Б., Jin, J. J., et al. (2018) · ACS Central Science · doi:10.1021/acscentsci.8b00239 · Cited by 91

DEVELOPMENT OF IMMUNOLOGICAL CAPACITY UNDER GERMFREE AND CONVENTIONAL CONDITIONS

Tlaskalová‐Hogenová, H., Šterzl, J., Štëpánková, R., Dlabač, V., Větvička, V., Rossmann, P., Mandel, L., & Rejnek, J. (1983) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1983.tb26862.x · Cited by 91

Orthogonal Dietary Niche Enables Reversible Engraftment of a Gut Bacterial Commensal

Kearney, S. M., Gibbons, S. M., Erdman, S. E., & Alm, E. J. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.07.032 · Cited by 90

Effects of metformin, acarbose, and sitagliptin monotherapy on gut microbiota in Zucker diabetic fatty rats

Zhang, M., Feng, R., Yang, M., Cheng, Q., Wang, Z., Liu, W., & Ma, J. (2019) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2019-000717 · Cited by 90

Old drug new use - Amoxapine and its metabolites as potent bacterial β-glucuronidase inhibitors for alleviating cancer drug toxicity

Kong, R., Liu, T., Zhu, X., Ahmad, S., Williams, A. L., Phan, A. T., Zhao, H., Scott, J. E., Yeh, L.-A., & Wong, S. T. C. (2014) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-0395 · Cited by 90

Probiotics in Clostridium difficile Infection

Na, X., & Kelly, C. P. (2011) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0b013e31822ec787 · Cited by 88

Microencapsulated Genetically Engineered Lactobacillus plantarum 80 (pCBH1) for Bile Acid Deconjugation and Its Implication in Lowering Cholesterol

Jones, M. L., Chen, H., Ouyang, W., Metz, T., & Prakash, S. (2004) · BioMed Research International · doi:10.1155/s1110724304307011 · Cited by 86

The human microbiome encodes resistance to the antidiabetic drug acarbose

Balaich, J. N., Estrella, M. A., Wu, G. G., Jeffrey, P. D., Biswas, A. G., Zhao, L., Korennykh, A. V., & Donia, M. S. (2021) · Nature · doi:10.1038/s41586-021-04091-0 · Cited by 85

Recording mobile DNA in the gut microbiota using an Escherichia coli CRISPR-Cas spacer acquisition platform

Munck, C., Sheth, R. U., Freedberg, D. E., & Wang, H. H. (2020) · Nature Communications · doi:10.1038/s41467-019-14012-5 · Cited by 83

Inhibition of microbial sulfate reduction in a flow-through column system by (per)chlorate treatment

Engelbrektson, A. L., Hubbard, C. G., Tom, L. M., Boussina, A. E., Jin, Y. T., Wong, H., Piceno, Y. M., Carlson, H. K., Conrad, M. E., Anderson, G., et al. (2014) · Frontiers in Microbiology · doi:10.3389/fmicb.2014.00315 · Cited by 79

Widespread Use of the Nitrification Inhibitor Nitrapyrin: Assessing Benefits and Costs to Agriculture, Ecosystems, and Environmental Health

Woodward, E. E., Edwards, T. M., Givens, C. E., Kolpin, D. W., & Hladik, M. L. (2021) · Environmental Science & Technology · doi:10.1021/acs.est.0c05732 · Cited by 79

Tungstate as an antagonist of molybdate in Azotobacter vinelandii

KEELER, R. F., & Varner, J. E. (1957) · Archives of Biochemistry and Biophysics · doi:10.1016/0003-9861(57)90146-7 · Cited by 76

Probing the reactivity of Ni in the active site of methyl-coenzyme M reductase with substrate analogues

Goenrich, M., Mahlert, F., Duin, E. C., Bauer, C., Jaun, B., & Thauer, R. K. (2004) · JBIC Journal of Biological Inorganic Chemistry · doi:10.1007/s00775-004-0552-1 · Cited by 75

Sulfonates as Terminal Electron Acceptors for Growth of Sulfite-Reducing Bacteria (Desulfitobacteriumspp.) and Sulfate-Reducing Bacteria: Effects of Inhibitors of Sulfidogenesis

Lie, T. J., Godchaux, W., & Leadbetter, E. R. (1999) · Applied and Environmental Microbiology · doi:10.1128/aem.65.10.4611-4617.1999 · Cited by 74

Stable Neutralization of a Virulence Factor in Bacteria Using Temperate Phage in the Mammalian Gut

Hsu, B. B., Way, J. C., & Silver, P. A. (2020) · mSystems · doi:10.1128/msystems.00013-20 · Cited by 74

Molecular Basis of C–N Bond Cleavage by the Glycyl Radical Enzyme Choline Trimethylamine-Lyase

Bodea, S., Funk, M. A., Balskus, E. P., & Drennan, C. L. (2016) · Cell chemical biology · doi:10.1016/j.chembiol.2016.07.020 · Cited by 73

Competitive and Non-competitive Inhibitors of Bacterial Sulphate Reduction

Postgate, J. R. (1952) · Journal of General Microbiology · doi:10.1099/00221287-6-1-2-128 · Cited by 72

Activity-based protein profiling in bacteria: Applications for identification of therapeutic targets and characterization of microbial communities

Keller, L. J., Babin, B. M., Lakemeyer, M., & Bogyo, M. S. (2019) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2019.10.007 · Cited by 72

Gut bacterial microbiome composition and statin intake—A systematic review

Dias, A. M., Cordeiro, G., Estevinho, M. M., Veiga, R., Figueira, L., Reina‐Couto, M., & Magro, F. (2020) · Pharmacology Research & Perspectives · doi:10.1002/prp2.601 · Cited by 71

Targeting Regorafenib-Induced Toxicity through Inhibition of Gut Microbial β-Glucuronidases

Ervin, S. M., Hanley, R. P., Lim, L., Walton, W. G., Pearce, K. H., Bhatt, A. P., James, L. I., & Redinbo, M. R. (2019) · ACS Chemical Biology · doi:10.1021/acschembio.9b00663 · Cited by 71

Discovering the Microbial Enzymes Driving Drug Toxicity with Activity-Based Protein Profiling

Jariwala, P. B., Pellock, S. J., Goldfarb, D., Cloer, E. W., Artola, M., Simpson, J. B., Bhatt, A. P., Walton, W. G., Roberts, L. R., Major, M. B., et al. (2019) · ACS Chemical Biology · doi:10.1021/acschembio.9b00788 · Cited by 70

Gnotobiotic Rodents: An In Vivo Model for the Study of Microbe–Microbe Interactions

Martín, R., Bermúdez‐Humarán, L. G., & Langella, P. (2016) · Frontiers in Microbiology · doi:10.3389/fmicb.2016.00409 · Cited by 68

Anaerobic microbial community response to methanogenic inhibitors 2‐bromoethanesulfonate and propynoic acid

Webster, T. M., Smith, A. L., Reddy, R. R., Pinto, A. J., Hayes, K. F., & Raskin, L. M. (2016) · MicrobiologyOpen · doi:10.1002/mbo3.349 · Cited by 67

Structure-Guided Identification of a Small Molecule That Inhibits Anaerobic Choline Metabolism by Human Gut Bacteria

Orman, M., Bodea, S., Funk, M. A., Campo, A. M.-D., Bollenbach, M., Drennan, C. L., & Balskus, E. P. (2018) · Journal of the American Chemical Society · doi:10.1021/jacs.8b04883 · Cited by 64

Tungstate as a competitive inhibitor of molybdate in nitrite assimilation and in N2 fixation by Azotobacter

Takahashi, H., & Nason, A. (1957) · Biochimica et Biophysica Acta · doi:10.1016/0006-3002(57)90351-7 · Cited by 63

Metformin Strongly Affects Gut Microbiome Composition in High-Fat Diet-Induced Type 2 Diabetes Mouse Model of Both Sexes

Silamiķele, L., Silamiķelis, I., Ustinova, M., Kalniņa, Z., Elbere, I., Petrovska, R., Kalniņa, I., & Kloviņš, J. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.626359 · Cited by 63

Tissue Distribution of Tungsten in Mice Following Oral Exposure to Sodium Tungstate

Guandalini, G. S., Zhang, L., Fornero, E., Centeno, J. A., Mokashi, V. P., Ortiz, P. A., Stockelman, M. D., Osterburg, A. R., & Chapman, G. G. (2011) · Chemical Research in Toxicology · doi:10.1021/tx200011k · Cited by 62

Baseline gut microbiome composition predicts metformin therapy short-term efficacy in newly diagnosed type 2 diabetes patients

Elbere, I., Silamiķelis, I., Dindune, I. I., Kalniņa, I., Briviba, M., Zaharenko, L., Silamiķele, L., Rovīte, V., Gudrā, D., Konrāde, I., et al. (2020) · PLoS ONE · doi:10.1371/journal.pone.0241338 · Cited by 61

Interaction of antidiabetic α‐glucosidase inhibitors and gut bacteria α‐glucosidase

Tan, K., Tesar, C., Wilton, R., Jedrzejczak, R. P., & Joachimiak, A. (2018) · Protein Science · doi:10.1002/pro.3444 · Cited by 60

Rosuvastatin alters the genetic composition of the human gut microbiome

Kummen, M., Solberg, O. G., Storm-Larsen, C., Holm, K., Ragnarsson, A., Trøseid, M., Vestad, B., Skårdal, R., Yndestad, A., Ueland, T., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-62261-y · Cited by 58

Discovery of Bile Salt Hydrolase Inhibitors Using an Efficient High-Throughput Screening System

Smith, K., Zeng, X., & Lin, J. (2014) · PLoS ONE · doi:10.1371/journal.pone.0085344 · Cited by 57

The effect of 2-chloro, 6-(trichloromethyl) pyridine on the chemoautotrophic metabolism of nitrifying bacteria

Campbell, N. E. R., & Aleem, M. (1965) · Antonie van Leeuwenhoek · doi:10.1007/bf02045882 · Cited by 57

A Gut-Restricted Lithocholic Acid Analog as an Inhibitor of Gut Bacterial Bile Salt Hydrolases

Adhikari, A. A., Ramachandran, D., Chaudhari, S. N., Powell, C. E., Li, W., McCurry, M. D., Banks, A. S., & Devlin, A. S. (2021) · ACS Chemical Biology · doi:10.1021/acschembio.1c00192 · Cited by 56

Revealing quantum mechanical effects in enzyme catalysis with large-scale electronic structure simulation

Yang, Z. J., Mehmood, R., Wang, M., Qi, H. W., Steeves, A. H., & Kulik, H. J. (2018) · Reaction Chemistry & Engineering · doi:10.1039/c8re00213d · Cited by 53

Properties of the periplasmic nitrate reductases from Paracoccus pantotrophus and Escherichia coli after growth in tungsten-supplemented media

Gates, A. J., Hughes, R. O., Sharp, S. R., Millington, P. D., Nilavongse, A., Cole, J. A., Leach, E.-R., Jepson, B., Richardson, D. J., & Butler, C. S. (2003) · FEMS Microbiology Letters · doi:10.1016/s0378-1097(03)00122-8 · Cited by 53

Competitive Inhibition of Sulphate Reduction by Selenate

Postgate, J. R. (1949) · Nature · doi:10.1038/164670b0 · Cited by 52

Discovery and mining of enzymes from the human gut microbiome

Jia, B., Han, X., Kim, K. H., & Jeon, C. O. (2021) · Trends in biotechnology · doi:10.1016/j.tibtech.2021.06.008 · Cited by 52

High-throughput time-resolved morphology screening in bacteria reveals phenotypic responses to antibiotics

Zahir, T., Camacho, R., Vitale, R., Ruckebusch, C., Hofkens, J., Fauvart, M., & Michiels, J. J. (2019) · Communications Biology · doi:10.1038/s42003-019-0480-9 · Cited by 52

Alpha-Glucosidase Inhibitors Alter Gut Microbiota and Ameliorate Collagen-Induced Arthritis

Zhang, L., Song, P., Zhang, X., Metea, C., Schleisman, M., Karstens, L., Leung, E. T., Zhang, J., Xu, Q., Liu, Y., et al. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.01684 · Cited by 51

Inhibitory effect of some intestinal bacteria on liver tumorigenesis in gnotobiotic male mice

Mizutani, T., & MITSUOKA, T. (1980) · Cancer Letters · doi:10.1016/0304-3835(80)90098-1 · Cited by 51

Microbiota–gut–brain axis and its therapeutic applications in neurodegenerative diseases

Loh, J. S., Mak, W. Q., Tan, L. K. S., Ng, C. X., Chan, H. H., Yeow, S. H., Foo, J. B., Ong, Y. S., How, C. W., & Khaw, K. Y. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01743-1 · Cited by 1,193

Another renaissance for bile acid gastrointestinal microbiology

Ridlon, J. M., & Gaskins, H. R. (2024) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-024-00896-2 · Cited by 205

Hydrogen sulfide produced by the gut microbiota impairs host metabolism via reducing GLP-1 levels in male mice

Qi, Q., Zhang, H., Jin, Z., Wang, C., Xia, M., Chen, B., Lv, B., Diaz, L. P., Li, X., Feng, R., et al. (2024) · Nature Metabolism · doi:10.1038/s42255-024-01068-x · Cited by 129

Horizon scanning the application of probiotics for wildlife

Garcías-Bonet, N., Roik, A., Tierney, B. T., García, F. C., Villela, H., Dungan, A. M., Quigley, K. M., Sweet, M. J., Berg, G., Gram, L., et al. (2023) · Trends in Microbiology · doi:10.1016/j.tim.2023.08.012 · Cited by 81

Pharmacomicrobiomics: The Role of the Gut Microbiome in Immunomodulation and Cancer Therapy

Bolte, L. A., Björk, J. R., Gaćeša, R., & Weersma, R. K. (2025) · Gastroenterology · doi:10.1053/j.gastro.2025.04.025 · Cited by 39

Drugging the gut microbiota: toward rational modulation of bacterial composition in the gut

Altamura, F., Maurice, C. F., & Castagner, B. (2019) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2019.09.005 · Cited by 17

Drugging the microbiome: targeting small microbiome molecules

Sharma, S., Hegde, P. V., Panda, S., Orimoloye, M. O., & Aldrich, C. C. (2022) · Current Opinion in Microbiology · doi:10.1016/j.mib.2022.102234 · Cited by 2

Probing and manipulating the gut microbiome with chemistry and chemical tools

Mantravadi, P. K., Kovi, B. S., Reddy, S. R., Pandian, G. N., Kalesh, K., & Parthasarathy, A. (2025) · Gut Microbiome · doi:10.1017/gmb.2025.4 · Cited by 4

Discovery of small molecule enzyme inhibitors from gut microbes as potential antiinflammatory and anticancer agents

Stierle, A. A. (2013) · Journal of Postgenomics Drug & Biomarker Development

Deciphering Human Microbiota–Host Chemical Interactions

Silpe, J. E., & Balskus, E. P. (2020) · ACS Central Science · doi:10.1021/acscentsci.0c01030 · Cited by 43